TY - JOUR
T1 - Myocardial oxidative metabolism is increased due to haemodynamic overload in patients with aortic valve stenosis
T2 - Assessment using 11C-acetate positron emission tomography
AU - Naya, Masanao
AU - Chiba, Satoru
AU - Iwano, Hiroyuki
AU - Yamada, Satoshi
AU - Katoh, Chietsugu
AU - Manabe, Osamu
AU - Yoshinaga, Keiichiro
AU - Matsui, Yoshiro
AU - Tamaki, Nagara
AU - Tsutsui, Hiroyuki
N1 - Funding Information:
Acknowledgments This study was supported in part by the Grants-in-Aid for Young Scientists (20790871) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MN) and in part by the Mochida Memorial Foundation for Medical and Pharmaceutical Research (MN).
PY - 2010/12
Y1 - 2010/12
N2 - Purpose: The relationship between myocardial oxidative metabolism and pressure overload in aortic valve stenosis (AS) is not fully elucidated. We identified the determinants of myocardial oxidative metabolism by measuring its changes after aortic valve replacement (AVR) in patients with AS. Methods: Myocardial 11C-acetate clearance rate constant (Kmono), an index of oxidative metabolism, was measured non-invasively by using positron emission tomography in 16 patients with moderate to severe AS and 7 healthy controls. The severity of AS was assessed by echocardiography. Of 16 patients, 5 were reexamined at 1 month after AVR. Results: Kmono was significantly higher in patients with AS than healthy controls by 42% (0.068±0.014 vs 0.048±0.007/min, p<0.01). Kmono was significantly correlated with age (r=0.58, p<0.01), left ventricular (LV) mass index (r=0.61, p<0.01) and estimated systolic LV pressure (r=0.81, p<0.001) measured by echocardiography. By multivariate analysis, estimated LV systolic pressure was an independent predictor of Kmono (β=0.93, p<0.01). After AVR, Kmono (from 0.075±0.012 to 0.061±0.014/min, p=0.043) and LV mass index (from 183±49 to 124±41 g/ml2, p=0.043) were significantly decreased despite no significant changes in rate-pressure product. Conclusion: Myocardial oxygen metabolism was increased in patients with AS, which was decreased after AVR. The increased myocardial oxidative metabolism in AS was largely attributable to the pressure overload of the LV.
AB - Purpose: The relationship between myocardial oxidative metabolism and pressure overload in aortic valve stenosis (AS) is not fully elucidated. We identified the determinants of myocardial oxidative metabolism by measuring its changes after aortic valve replacement (AVR) in patients with AS. Methods: Myocardial 11C-acetate clearance rate constant (Kmono), an index of oxidative metabolism, was measured non-invasively by using positron emission tomography in 16 patients with moderate to severe AS and 7 healthy controls. The severity of AS was assessed by echocardiography. Of 16 patients, 5 were reexamined at 1 month after AVR. Results: Kmono was significantly higher in patients with AS than healthy controls by 42% (0.068±0.014 vs 0.048±0.007/min, p<0.01). Kmono was significantly correlated with age (r=0.58, p<0.01), left ventricular (LV) mass index (r=0.61, p<0.01) and estimated systolic LV pressure (r=0.81, p<0.001) measured by echocardiography. By multivariate analysis, estimated LV systolic pressure was an independent predictor of Kmono (β=0.93, p<0.01). After AVR, Kmono (from 0.075±0.012 to 0.061±0.014/min, p=0.043) and LV mass index (from 183±49 to 124±41 g/ml2, p=0.043) were significantly decreased despite no significant changes in rate-pressure product. Conclusion: Myocardial oxygen metabolism was increased in patients with AS, which was decreased after AVR. The increased myocardial oxidative metabolism in AS was largely attributable to the pressure overload of the LV.
UR - https://www.scopus.com/pages/publications/78649780158
UR - https://www.scopus.com/pages/publications/78649780158#tab=citedBy
U2 - 10.1007/s00259-010-1540-z
DO - 10.1007/s00259-010-1540-z
M3 - Article
C2 - 20661559
AN - SCOPUS:78649780158
SN - 1619-7070
VL - 37
SP - 2242
EP - 2248
JO - European Journal of Nuclear Medicine and Molecular Imaging
JF - European Journal of Nuclear Medicine and Molecular Imaging
IS - 12
ER -